Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 0378-4288

5 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 0378-4288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eletriptan Hydrobromide Structural Formula (Image 01)

Eletriptan Hydrobromide Structural Formula (Image 01)
Chemical structure of eletriptan hydrobromide, showing its molecular arrangement including a sulfonamide group, an indole ring, and a methyl-substituted pyrrolidine ring attached to the hydrobromide salt.*
FDA Label Image

Figure 1: Estimated Probability Of Initial Headache Response Within 2 Hours* (Image 02)

Figure 1: Estimated Probability Of Initial Headache Response Within 2 Hours* (Image 02)
A line graph depicting the estimated probability of response over time from initial dose in hours. It compares response rates for double-blind placebo and eletriptan tablets in 20 mg, 40 mg, and 80 mg strengths up to 2 hours after dosing.*
FDA Label Image

Figure 2: Estimated Probability Of Taking A Second Dose/other Medication Over The 24 Hours Following The First Dose* (Image 03)

Figure 2: Estimated Probability Of Taking A Second Dose/other Medication Over The 24 Hours Following The First Dose* (Image 03)
A line graph showing the probability of a second dose or other medication use over 24 hours after the initial dose. It compares four groups: double-blind placebo, eletriptan 20 mg, eletriptan 40 mg, and eletriptan 80 mg. The x-axis represents time in hours, and the y-axis represents the probability, ranging from 0 to 0.9.*
FDA Label Image

Eletriptan Hydrobromide Tablets 20 mg Bottle Label (Image 04)

Eletriptan Hydrobromide Tablets 20 mg Bottle Label (Image 04)
Box packaging label for Eletriptan Hydrobromide 20 mg film-coated tablets by Mylan Pharmaceuticals Inc. The label indicates 6 unit-dose tablets with a round, orange tablet imprinted with EL4. It includes the NDC 0378-4287-85, storage instructions, and a barcode. Manufactured for Mylan Pharmaceuticals Inc.*
FDA Label Image

Eletriptan Hydrobromide Tablets 40 mg Bottle Label (Image 05)

Eletriptan Hydrobromide Tablets 40 mg Bottle Label (Image 05)
Packaging label for Eletriptan Hydrobromide 40 mg film-coated tablets from Mylan Pharmaceuticals Inc. The label indicates 6 unit-dose tablets per package with the NDC 0378-4288-85. The tablet is round, orange, and marked with 'ELS'. Storage instructions and regulatory information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.